“The health system decides a different kind of technologies that can be used to treat disease, and there are several medical devices available at its cost. But the medical devices have to undergo reviews before it is accessible to physicians, and it is because of the lack of transparency in terms of clinical evidence for the medical device.”
Need for Availability & Access to Clinical Evidence for Medical devices for Europe.
March 11, 20200

Related Articles
March 10, 20200
Pepgra, Scientific and Regulatory CRO Firm, the brand of Guires, UK
Guires, a leading player in the Indian market has recently made an entry into the UK market. Guires has under its aegis a brand ‘Pepgra’, which excl
Read More
March 10, 20200
Pubrica Clinical and Medical Scientific Writing and Publication Support, a unit of Guires, UK
Pubrica, another brand established and owned by Guires, extends services to authors and publishers by providing services in the domain of medical an
Read More
March 31, 20200
Guires, part of digital conversation on Tuesday – Manchester and India – the Digital Opportunity
A panel discussion on ‘The Digital Opportunity’ offers the perfect platform to meet, interact and share ideas about how ‘digital’ is transforming th
Read More

Comment here